The Medicines Company to Participate in the Bank of America Merrill Lynch 2017 Health Care Conference

04 May 2017

The Medicines Company (NASDAQ:MDCO) today announced that it will participate in the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16, 2017, in Las Vegas, Nevada. Clive Meanwell, M.D., Ph.D., Chief Executive Officer, will participate in a fireside chat at 8:00 a.m., Pacific Daylight Time.

A live audio webcast will be available in the “Investors-Events/Presentations” section of The Medicines Company website. A replay of the fireside chat will be available for approximately 90 days.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.


Contacts

The Medicines Company
Media
Meg Langan, 973-290-6319
Vice President
margaret.langan@themedco.com
or
Investor Relations
Krishna Gorti, M.D., 973-290-6122
Vice President, Investor Relations
krishna.gorti@themedco.com

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information

Human Resources
Verification of employment
Tel 973 290 6361
Fax 862 207 6361

Investors Relations

Krishna Gorti, MD
Tel 973 290 6122
krishna.gorti@themedco.com

Media Inquiries

Michael Blash
Tel 973 290 6100
michael.blash@themedco.com